You're both completely right, but remember that government

New Post Public Reply Private Reply Replies (0) Message Board
adirondackhi robinsonst1 #51420
623
You're both completely right, but remember that government agencies don't give a crap whether or not their positions on a subject make any sense, only that their asses are covered.

Until they have indisputable clinical proof from fully accredited government facilities, they don't care if 99% of the most prestigious research centers in the world are singing the praises of how good something is for you.

How much CBD a person gets from normal doses of THC from MJ usage is known to be much lower than high doses of high quality CBD supplements.

While there is a tremendous amount of research that has been and still is being done on the ingestion of CBD and the fantastic health benefits revealed from it, government agencies are still not about to approve the use of more concentrated, higher doses.

They need the CYA confirmation of fully government accredited labs signing off on it as being low or no risk, even if not immediately pursuing the testing so far as to determine long or even short term health benefits which is much more costly to do.

They don't take it that far with supplements, even most vitamins. I take one called Trans-Resveratrol with added polyphenols. Very prestigious but independent research has determined it to be one of the most potent antioxidants ever discovered and isolated and extremely beneficial to one's overall immune health, but on the label is the old CYA statement: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease".

Well, it's been determined by many of the best research groups in the world to be one of the best disease preventing supplements you can take, but it could be quite a wait to get the FDA's stamp of approval. They simply won't hurry to subsidize clinical research on most of those non-patentable preventative supplements because there's not much capital pushing for it like there are with patentable drugs.

CBD is definitely not in the same boat with most non-patentable supplements. We're talking billions hanging on full CBD approval, so it should be no surprise that the research is already underway in those government accredited laboratories. It won't be long and the green lights will be shining bright in the U.S. and Canada.

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ian Marx Wins Pro Bono Honor at NJ Legal Awards

Updated Category News Views 81

A Champion in Legal Advocacy How often do we hear about a lawyer choosing the unglamorous path of pro bono work over the high-stakes allure of corporate law? Slam-dunk, you don’t. At the New Jersey Legal Awards, Ian S. Marx from Greenberg Traurig broke the mold, snagging the 'Pro Bono Lawyer of the Year' award. This isn’t just some pat on the back; it's recognition of...

Continue Reading
Seaboard's Q3 Financials: A Mixed Bag for Investors

Updated Category News Views 124

Eyeing Seaboard's Earnings: What's the Deal? Seaboard Corporation just dropped its earnings report for the third quarter, and boy, it's a doozy. The numbers show a mixed bag—like finding out your favorite team won, but your best player got benched with an injury. On the surface, we've got a rise in net sales, but dig a little deeper, and the cracks start to show. Sales...

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 101

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Sandals & Beaches Black Friday: Up to 65% Savings

Updated Category News Views 102

Vacation Savings So Sweet They’re Hard to Ignore If you’ve been dreaming of a sun-soaked escape, Sandals and Beaches Resorts have rolled out deals so compelling, they’re practically begging you to pack your bags. This year, from November 3 until December 1, travelers can dive into savings of up to 65% combined with air credits reaching up to $750. In a move clearly...

Continue Reading
Havertys Q3 Upswing Amid Tariffs and Tight Margins

Updated Category News Views 21

Havertys Delivers a Steady Third Quarter Amid Challenges Alright investors, Havertys Furniture (NYSE:HVT) just rolled out its Q3 numbers for 2026 and folks, it looks like this furniture staple is holding its ground pretty well against a backdrop rife with economic headwinds. Quarterly Numbers: A Mix of Hope and Hurdles If you’re keeping score, diluted EPS stepped up...

Continue Reading
Autohome's 2026 Q3 Results: Revenue Dips But Optimism Glows

Updated Category News Views 53

A Rollercoaster Quarter for Autohome Diving right into Autohome's latest financial results, and boy, it's not the cheeriest news we've heard. For Q3 2026, the famed online auto hub's net revenue is down to RMB1,315.0 million from RMB1,778.1 million a year prior. That's a hefty slide in any trader's book. More so, net income attributable to the company tumbled from...

Continue Reading
Memoir 'Pinball' Explores Life's Unpredictable Momentum

Updated Category News Views 91

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

Continue Reading
Maple Leaf Foods' Q3 Results: Growth Amidst Inflation

Updated Category News Views 12

Navigating Inflationary Waters: A Maple Leaf Foods Update Seeing Maple Leaf Foods (TSX: MFI) push through a tough inflationary landscape with a 15.4% rise in EBITDA would make any seasoned investor nod in respect. They've gone from last year's $111.7 million to a hefty $129 million in Q3 2026. What's more, their EBITDA margin climbed to 12.5%, up 140 basis points from...

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 114

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
Adient Boosts Buyback, Shields Valuable Tax Assets

Updated Category News Views 16

Adient's Aggressive Buyback and Tax Strategy Well, it looks like Adient's not just sitting on its hands. They've not only opened up the cash taps with a $400 million increase in their share repurchase authorization but also shored up their defenses with a Tax Benefits Preservation Plan. You know, when a company dishes out that kind of cash, it tells you they see some...

Continue Reading

Top 5 Most Recently Viewed Articles

Alter Wolff Foley & Stutman LLP Achieves New Legal Milestones

Updated Category News Views 197

Alter Wolff Foley & Stutman LLP Receives Prestigious Honors Alter Wolff Foley & Stutman LLP, a distinguished family and matrimonial law firm, has proudly announced that several of its esteemed attorneys have received notable recognitions in significant legal accolades. The firm, recognized for its exceptional proficiency in family law, saw its members listed among the...

Continue Reading
Groupon, Inc. Under Scrutiny: What Investors Should Know

Updated Category News Views 271

Groupon, Inc. Faces Investigation Amid Fraud Allegations Pomerantz LLP is looking into claims on behalf of investors of Groupon, Inc. (NASDAQ: GRPN). Those who have invested in Groupon should take notice and consider their options seriously. The firm is reaching out to those impacted and encourages them to step forward. What's the Basis of the Investigation? The primary...

Continue Reading
Quantum Xchange Achieves Significant FIPS 140-3 Security Milestone

Updated Category News Views 118

Quantum Xchange Secures FIPS 140-3 Certification for Phio TX Quantum Xchange is excited to announce that its innovative, crypto-agile platform, Phio TX™, has recently achieved the prestigious FIPS 140-3 certification. This certification signifies that Phio TX meets the stringent security requirements set for cryptographic modules used by the government and various...

Continue Reading
Saia Expands Footprint with New Terminals in Ohio and Kentucky

Updated Category News Views 88

Saia Expands Footprint in Ohio and Kentucky Saia Inc. (NASDAQ: SAIA) is thrilled to announce its ongoing expansion efforts with the launch of three new terminals, aimed at enhancing service availability and efficiency. This exciting development includes the opening of a facility in Akron, Ohio, and two additional locations in Bowling Green and Paducah, Kentucky, which are...

Continue Reading
Constellation Brands Stock Faces Rough Waters at 52-Week Low

Updated Category News Views 121

Constellation Brands Stock Experiences Significant Low Constellation Brands Inc. (NYSE: STZ) recently reached a 52-week low, landing at $224.72. This marks a notable downturn for the beverage powerhouse, which boasts a diverse portfolio of beer, wine, and spirits. Despite this decline, the company maintains a commendable gross profit margin of 51%, remaining resilient...

Continue Reading